Exagen Inc reports results for the quarter ended in September - Earnings Summary

Exagen

14/11/2022 23:26

* Exagen Inc  XGN.OQ  reported a quarterly adjusted loss
of 47
cents​​ per share for the quarter ended in September. The mean
expectation of six analysts for the quarter was for a loss of 73
cents per share.
    * Revenue rose 20.2% to $14.73 million from a year ago;
analysts
expected $9.13 million. 
    * Exagen Inc's reported EPS for the quarter was a loss of 47
cents​.
    * The mean earnings estimate of analysts had risen by
about 3.9%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Exagen Inc shares had fallen by 16.2% this quarter and
lost 80.5% so far this year.
    * The company reported a quarterly loss of $8.1 million.
    * Wall Street's median 12-month price target for Exagen Inc
is
$10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
14 at 11:26 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.73          -0.47          Beat
 Jun. 30 2022      -0.57          -0.78          Missed
 Mar. 31 2022      -0.61          -0.60          Beat
 Dec. 31 2021      -0.50          -0.42          Beat